Piper Sandler analyst Jessica Tassan raised the firm’s price target on Alignment Healthcare (ALHC) to $30 from $20 and keeps an Overweight rating on the shares. The firm is updating its model to reflect strong AEP sales and retention during Q4 2025 and higher resulting membership in 2026. Piper also refined its 2027 estimates and added 2028-2030.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare should be bought on recent selloff, says Baird
- Alignment Healthcare price target raised to $23 from $20 at JPMorgan
- Alignment Healthcare 11.119M share Block Trade priced at $18.70
- Alignment Healthcare upgraded to Overweight from Neutral at JPMorgan
- Alignment Healthcare’s Promising Growth Trajectory and Strategic Expansion: A Buy Recommendation by John Stansel